|
ROD1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.982500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.139970E-02 |
| Normal-vs-Stage2 |
2.536000E-03 |
| Normal-vs-Stage3 |
3.275900E-03 |
| Normal-vs-Stage4 |
4.776800E-01 |
| Stage1-vs-Stage2 |
2.850400E-01 |
| Stage1-vs-Stage3 |
5.212600E-01 |
| Stage1-vs-Stage4 |
7.984600E-01 |
| Stage2-vs-Stage3 |
8.232400E-01 |
| Stage2-vs-Stage4 |
5.593200E-01 |
| Stage3-vs-Stage4 |
6.197600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.896000E-03 |
| Normal-vs-AfricanAmerican |
2.556000E-02 |
| Normal-vs-Asian |
1.474400E-02 |
| Caucasian-vs-AfricanAmerican |
5.654200E-01 |
| Caucasian-vs-Asian |
3.681400E-01 |
| AfricanAmerican-vs-Asian |
2.659200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.798800E-04 |
| Normal-vs-Female |
2.383800E-01 |
| Male-vs-Female |
1.555690E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.449530E-02 |
| Normal-vs-Extreme_Weight |
1.848500E-04 |
| Normal-vs-Obese |
1.749960E-01 |
| Normal-vs-Extreme_Obese |
6.882000E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.494800E-01 |
| Normal_Weight-vs-Obese |
1.686970E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.861200E-01 |
| Extreme_Weight-vs-Obese |
3.159700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.947200E-01 |
| Obese-vs-Extreme_Obese |
1.713960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.594370E-01 |
| Normal-vs-Age(41-60Yrs) |
7.517800E-02 |
| Normal-vs-Age(61-80Yrs) |
2.639500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.696100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.457200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.010400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.728370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.610500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.658000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.814200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.035000E-03 |
| Normal-VS-Type2 PRCC |
2.615500E-03 |
| Normal-VS-KIRP CIMP |
3.405400E-01 |
| Normal-VS-Unclassified PRCC |
4.465000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.789800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.824100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.876000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.137700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.796400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.475700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.69859999965949E-07 |
| Normal-vs-N1 |
2.392000E-01 |
| Normal-vs-N2 |
8.716200E-01 |
| N0-vs-N1 |
1.210320E-02 |
| N0-vs-N2 |
4.369000E-01 |
| N1-vs-N2 |
7.095200E-01 |
|
|
